GR Silver arranges $13-million bought deal

Executive Summary

• GR Silver Mining Ltd. has entered into a bought deal agreement for $13 million in aggregate gross proceeds, consisting of a $10 million LIFE offering and a $3 million private placement.
• The company is issuing 43,334,000 units at a price of 30 cents per unit, with net proceeds designated for the advancement of the Plomosas project in Mexico, working capital, and general corporate purposes.
• Each unit comprises one common share and one-half of a common share purchase warrant, exercisable at 42 cents per share for 36 months, with closing expected around the week of December 15, 2025.

Key Details

• Transaction Structure: Bought deal offering of 43,334,000 units at $0.30 per unit.
• Aggregate Gross Proceeds: $13,000,200.
• LIFE Offering Component:
  • 33,334,000 units issued on a prospectus-exempt basis under the Listed Issuer Financing Exemption (LIFE).
  • Gross proceeds: $10,000,200.
  • Units are immediately free trading under applicable Canadian securities laws.
  • Offered in all Canadian provinces except Quebec and other qualifying jurisdictions including the US.
• Private Placement Component:
  • 10,000,000 units issued under National Instrument 45-106.
  • Gross proceeds: $3,000,000.
  • Offered to accredited investors in Canada and potentially the US.
  • Statutory hold period of four months and one day from closing.
• Warrant Terms:
  • Each unit includes one-half of one common share purchase warrant.
  • Exercise price: $0.42 per common share.
  • Duration: 36 months following closing.
• Underwriter Option:
  • Option to increase LIFE offering by up to 3,999,333 units.
  • Option to increase private placement by up to 15% in units.
  • Exercisable up to 48 hours prior to closing.
• Underwriter Compensation:
  • Cash commission: 6.0% of aggregate gross proceeds.
  • Broker warrants: Equal to 6.0% of the number of units sold.
  • Broker warrant terms: Exercise price equal to the offering price ($0.30), exercisable for 36 months following closing.
• Use of Proceeds: Advancement of the Plomosas project in Mexico, working capital, and general corporate purposes.
• Closing Date: Expected on or about the week of December 15, 2025, subject to regulatory approvals including TSX Venture Exchange conditional approval.
• Bookrunner: Research Capital Corp.

Notable Quotes

• None provided in the text.